RxDoctor Payments Data

Jennifer McAlister, MD

Surgical Oncology · Hendersonville, NCNPI 1578514519

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $182 and has fallen 90.2% since, to $18 in 2022. That places this record below the midpoint for surgical oncology clinicians in NC, where the typical reported total is $1,293.

$258in general payments, 2019–2025

Across 18 payments — averaging $14.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$49
  • Incyte Corporation$36
  • Tactile Systems Technology Inc$33
  • Amgen$27
  • Merck$26
  • Sanofi$21
  • plus $67 from 5 others

What the payments were for

  • Food & beverage$258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$258 in reported general payments places this provider in the 25th percentile of 34 surgical oncology providers in North Carolina.

See all surgical oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$137,104
Medicare patients
394
Services billed
856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl113$195

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Hendersonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →